Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Revenue

Bukwang Pharmaceutical had revenue of 47.81B KRW in the quarter ending March 31, 2025, with 39.00% growth. This brings the company's revenue in the last twelve months to 173.50B, up 40.96% year-over-year. In the year 2024, Bukwang Pharmaceutical had annual revenue of 160.09B with 27.13% growth.

• Revenue (ttm): 173.50B
• Revenue Growth: +40.96%
• P/S Ratio: 1.59
• Revenue / Employee: 286.30M
• Employees: 606
• Market Cap: 275.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	160.09B	34.16B	27.13%
Dec 31, 2023	125.93B	-64.98B	-34.04%
Dec 31, 2022	190.91B	8.42B	4.61%
Dec 31, 2021	182.49B	12.83B	7.56%
Dec 31, 2020	169.66B	1.47B	0.87%